The bill requires the Board of Registration in Pharmacy to produce an annual report that details all investigatory and disciplinary actions taken throughout the year. This report must include specific information on each complaint, such as the date, alleged violation, collaboration with other agencies, and the Board's final decision. The report is mandated to be publicly accessible, including online publication on the Department of Public Health's website, thereby promoting transparency and accountability in the Board's operations.

Furthermore, the bill addresses the rising number of investigations categorized as "Failure to Fill Rx Properly," which are now being reviewed by the Board as investigations rather than mere complaints. This allows the Board to assess whether further investigations or complaints against individual licensees are warranted. The bill also introduces new legal language that underscores the Board's commitment to monitoring various complaint types, including Inspectional Deficiencies and Drug Violations, while highlighting the increase in complaints and investigations in 2023 due to improved field presence and a more effective triage process.